Cargando…
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Autores principales: | Xu, Yan, Li, Yuan, Jin, Jiankang, Han, Guangchun, Sun, Chengcao, Pizzi, Melissa Pool, Huo, Longfei, Scott, Ailing, Wang, Ying, Ma, Lang, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Vellano, Christopher, Yang, Liuqing, Lin, Chunru, Kim, Youngsoo, MacLeod, A. Robert, Wang, Linghua, Wang, Zhenning, Song, Shumei, Ajani, Jaffer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992986/ https://www.ncbi.nlm.nih.gov/pubmed/33766033 http://dx.doi.org/10.1186/s12943-021-01351-5 |
Ejemplares similares
-
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
por: Xu, Yan, et al.
Publicado: (2019) -
LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2020) -
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020) -
An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue
por: Jin, Jiankang, et al.
Publicado: (2020) -
A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model
por: Jin, Jiankang, et al.
Publicado: (2023)